Total Funding
25
49
Total FundingDebt Financing raised
Growth Score
-7 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
195600
Valanbio Therapeutics is an early-stage anti-infectives company that develops novel antibiotics for Gram-negative organisms.
Moise Khayrallah: Chairman & Board of DirectorsPast Role: Aerial BioPharma, CEO & Co-Founder
Past Role: Sphinx Pharmaceuticals, CEO
About the Company
Valanbio Therapeutics is an early-stage anti-infectives company that develops novel antibiotics for Gram-negative organisms.
It is based in Raleigh, North Carolina.
